It is a pharma private limited company based in Delhi, Delhi, India, established in 2018.
2018 | Delhi, Delhi, India | ActiveMyrtle Pharmaceutical Private Limited, a active private limited company, was established on 30 September 2018 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U85320DL2018PTC339853. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Vijai Kumar Asthana (Director), Ranvijay Singh (Director), Neeraj Shukla (Director). It holds ₹0.90 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi, Delhi, 110082.
U85320DL2018PTC339853
339853
30 September 2018
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Myrtle Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijai Kumar Asthana | Director | 30 Sep 2018 | Current |
| Ranvijay Singh | Director | 30 Sep 2018 | Current |
| Neeraj Shukla | Director | 30 Sep 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Myrtle Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 106.45% increase. The company also saw a substantial improvement in profitability, with a 122.54% increase in profit. The company's net worth Soared by an impressive increase of 11.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Myrtle Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 2021 | Bank Of India | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Myrtle Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Myrtle Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myrtle Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Myrtle Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
The activity A charge with Bank Of India of Rs. 0.90 M registered on 14 Jan 2021 with Charge ID 100410704 was modified on 15 Nov 2021. was completed.
Myrtle Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was recorded as a recent event.
Progress on A charge with Bank Of India amounted to Rs. 0.90 M with Charge ID 100410704 was registered on 14 Jan 2021. was documented.
The activity Vijai Kumar Asthana was appointed as a Director was appointed as a Director on 30 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The activity Ranvijay Singh was appointed as a Director was appointed as a Director on 30 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
The CIN of Myrtle Pharmaceutical Private Limited is U85320DL2018PTC339853.
Myrtle Pharmaceutical Private Limited is headquartered at House No.605, Block-C, Phase - 2 Holambi Kalan, Delhi, Delhi, 110082.
Myrtle Pharmaceutical Private Limited was incorporated on 30 September 2018.
The current directors of Myrtle Pharmaceutical Private Limited are
The primary industry of Myrtle Pharmaceutical Private Limited is Pharma.
Myrtle Pharmaceutical Private Limited is unlisted.
The authorized capital of Myrtle Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX